Form 4: BioCardia CEO Peter Altman Acquires Additional Shares
SEC Form 4 Filing
BioCardia's President and CEO, Peter Altman, purchased 100 shares of common stock at $2.14 per share on April 15, 2025.
Summary
- On April 15, 2025, Peter Altman, the President and CEO of BioCardia, Inc., acquired 100 shares of the company's common stock.
- The purchase price was $2.14 per share.
- Following this transaction, Altman directly owns 112,720 shares of BioCardia's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but the small quantity limits the impact.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. This purchase by the CEO could be seen as a positive sign.
Stakeholder Impact
- The purchase may have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/15/2025 | Date of the transaction: Peter Altman purchased 100 shares of BioCardia common stock. |
| 04/17/2025 | Date of signature on the Form 4 filing. |
Keywords
BioCardia, Peter Altman, BCDA, share purchase, Form 4, insider trading, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.